| Dr John Fenning Steinman, DMD | |
|
161 Us Route 302, Barre, VT 05641 | |
| (802) 476-8700 | |
| Not Available |
| Full Name | Dr John Fenning Steinman |
|---|---|
| Gender | Male |
| Speciality | Dentist - Orthodontics And Dentofacial Orthopedics |
| Location | 161 Us Route 302, Barre, Vermont |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053357194 | NPI | - | NPPES |
| 1005331 | Medicaid | VT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223X0400X | Dentist - Orthodontics And Dentofacial Orthopedics | 016-0001168 (Vermont) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr John Fenning Steinman, DMD 110 Nelson St, Barre, VT 05641-3312 Ph: (802) 476-8700 | Dr John Fenning Steinman, DMD 161 Us Route 302, Barre, VT 05641 Ph: (802) 476-8700 |
News Archive
Meda has completed the acquisition of Alaven and has taken over its operations. The acquisition will benefit Meda both short term and long term. The acquisition will add the therapeutic focus to include both gastroenterology and women's health; areas that Meda operates in outside of the US. In addition, Alaven has a strategic OTC platform that accounts for approximately 25% of sales. Alaven will further diversify Meda's revenue base in the US, as well as serve as a platform for commercializing strategic pipeline opportunities.
Scientists from The Scripps Research Institute have been awarded $6.6 million from the National Institutes of Health to lead an investigation of Lassa fever virus, the most prevalent virus-induced hemorrhagic fever disease in Africa.
Despite increased vaccine distribution and a significant decrease in the number of COVID-19 cases in Canada, the future of the pandemic is still a major concern, based on the possibility of a resurgence in the short term as well as long term and an understanding of the future of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunity. It is not clear if the Canadian population will reach herd immunity or if there is a risk of future resurgence of the virus in the Fall or Winter.
Oncolytics Biotech Inc. announced today that the Cancer Therapy & Research Center at the University of Texas Health Science Center in San Antonio (CTRC) has started patient enrolment in a U.S. Phase 2 clinical trial using intravenous administration of REOLYSIN(R) in combination with gemcitabine (Gemzar(R)) in patients with advanced pancreatic cancer. The Principal Investigator is Dr. Monica Mita of the CTRC.
A new Tulane University School of Medicine study finds that the more fractured families are by domestic violence or trauma, the more likely that children will bear the scars down to their DNA.
› Verified 8 days ago
Stephen Hibbs, D.D.S Dentist Medicare: Not Enrolled in Medicare Practice Location: 189 N Main St, Barre, VT 05641 Phone: 802-476-6785 Fax: 802-476-4339 | |
Kate Morey, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 856 Us 302 Unit A, Barre, VT 05641 Phone: 802-391-0350 | |
Dr. Lynne Julia Addiego, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 161 Us Route 302 - Berlin, Barre, VT 05641 Phone: 802-476-8700 | |
Dr. James J Crumbaker, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 85 Washington St, Suite 1, Barre, VT 05641 Phone: 802-476-7162 Fax: 802-476-7120 | |
Dr. Richard C. Wollensak, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 2 Park St, Barre, VT 05641 Phone: 802-476-6061 | |
Robert A Davis, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 248 S Main St, Barre, Vt 05641, Barre, VT 05641 Phone: 802-476-6785 |